Adverse Reactions Associated with Biologics for Moderate-to-Severe Plaque Psoriasis

Article

In July, our table of the month sums up biologics approved for moderate-to-severe plaque psoriasis and common adverse events associated with these biologics.

Links to PDF 

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.